Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114588) titled 'Improving Sarcopenia in Cancer Patients Undergoing Chemotherapy With High-Protein Nutritional Supplementation' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Taiwan University Hospital
Condition:
Early-stage Sarcopenia in Adult Cancer Patients Undergoing Chemotherapy
Intervention:
Dietary Supplement: ETHANWELL BALANCED
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 23, 2025
Target Sample Size: 57
Countries of Recruitment:
Ta...